If you commercialize Molecular Diagnostics (MDx), develop Laboratory Developed Tests (LDTs), or conduct preclinical research, then your final kit, assay, or modality must have an extraordinary level of quality to comply with strict regulatory or study standards. In the case of oligonucleotide raw materials, the only option you should consider is Custom cGMP Oligos.
Manufacturing oligos under cGMP maximizes risk mitigation by minimizing the probability of contamination, mix-ups, deviations, failures, and other errors, which in turn ensure that the oligo products meet the stringent requirements of MDx, LDTs, and preclinical research.
Stay tuned for details coming this year. If you would like to learn more and possibly begin building a partnership now, then please complete the short request form below.
To continue reading please sign in or create an account.Don't Have An Account?